05012017Headline:

Southeast Pennsylvania, Pennsylvania

HomePennsylvaniaSoutheast Pennsylvania

    Heading
    • Hernia Mesh Cases Move Forward with MDL

      Hernia Mesh Cases Move Forward with MDL

      In December, I wrote a blog discussing the likelihood of MultiDistrict Litigation (MDL) for two manufacturers of a hernia mesh surgical device—Atrium Medical who produces C-Qur mesh and Ethicon, Inc., a subsidiary of Johnson & Johnson, who recalled their Physiomesh […]

    • Lyft: the Case Is Settled, but Not the Employment Classification

      Lyft: the Case Is Settled, but Not the Employment Classification

      A federal judge has accepted a $27 million settlement this month in a class-action lawsuit against one of the U.S.’s leading rideshare providers, Lyft. While this marks the end of a long road for drivers seeking fair compensation in the […]

    • Hyland’s Products Could Still Harm Your Baby

      Hyland’s Products Could Still Harm Your Baby

      On October 11, 2016, homeopathic medicine manufacturer Hyland’s issued a public letter to parents everywhere. Beginning with “Dear Moms and Dads…” the corporate communication went on to say that they would no longer be distributing their line of homeopathic teething […]

    • Is MiraLax Safe for Kids?

      Is MiraLax Safe for Kids?

      Even though the Mirlax label is not approved for anyone under the age of 17, pediatricians have been prescribing this constipation remedy to young children for years. Once thought gentle enough for daily use, ongoing complaints from distraught parents has […]

    • Potential Consolidation of Farxiga Cases Highlights Growing Risk

      Potential Consolidation of Farxiga Cases Highlights Growing Risk

      Earlier this month, Plaintiffs with current litigation against AstraZeneca and Bristol-Myers Squibb for injuries related to their SGLT2 diabetes drug, Farxiga, petitioned the U.S. Judicial Panel on Multidistrict Litigation (JPML) to consolidate their cases in the U.S. District Court of […]

    • More Trials Set for J&J’s Risperdal Despite Latest Settlement

      More Trials Set for J&J’s Risperdal Despite Latest Settlement

      Lawsuits against Johnson & Johnson (J&J) continued to increase in 2016, with new complaints filed over a mix of household items, drugs, and medical devices including Johnson’s Baby Powder, the DePuy and Pinnacle hip implants, the blood thinner Xarelto, and […]

    • Bayer Fails to Change

      Bayer Fails to Change

      On Thursday, December 29th, a petition was filed requesting that the Judicial Panel on Multidistrict Litigation (JPML) create a single docket for more than 100 lawsuits against the contraceptive device Mirena—all claiming that use of the product has resulted in […]

    • Consumers Suffer as Abilify Legal Woes Continue

      Consumers Suffer as Abilify Legal Woes Continue

      While those who suffer from schizophrenia, bipolar disorder, depression and other mental disorders might be familiar with Bristol-Meyers Squibb’s top-selling drug, Abilify (aripiprazole), they might not be aware of the ongoing controversy that has the pharmaceutical giant headed to court […]

    • As Damages Multiply, Is J&J Getting the Message?

      As Damages Multiply, Is J&J Getting the Message?

      Recently, a federal jury in Dallas, Texas ordered Johnson & Johnson and its subsidiary, DePuy Orthopaedics, to pay more than $1 billion to six plaintiffs in the third bellwether trial of a multidistrict litigation (MDL) over the DePuy Pinnacle artificial […]

    • MDL May Be on the Horizon for Hernia Mesh Lawsuits

      MDL May Be on the Horizon for Hernia Mesh Lawsuits

      On December 1st, the U.S. Judicial Panel on Multidistrict Litigation (JPML) began hearing oral arguments on the consolidation of at least 15 lawsuits filed by patients who have suffered alleged injuries resulting from the use of C-Qur polypropylene surgical mesh—an […]